How are TCF7L2 and Blutzucker related?

TCF7L2 (transcription factor 7-like 2) is a key regulator of glucose metabolism. Certain risk variants (especially rs7903146) are among the strongest genetic predictors of type 2 diabetes. The link to blood sugar arises from impaired insulin secretion: carriers of the risk allele show reduced insulin release from pancreatic beta cells, particularly after glucose challenge. Incretin (GLP-1) response is also blunted. The effect size is moderate but consistently replicated across many populations. Importantly, TCF7L2 variants explain only a small fraction of individual diabetes risk; lifestyle factors (diet, physical activity, body weight) have a much larger impact. A genetic test alone is insufficient for clinical risk assessment. The evidence comes from large GWAS and functional studies and is considered human-strong. Caveat: while the genotype–phenotype relationship is well established, the clinical utility for personalized recommendations remains limited because no specific intervention is known to directly counteract the effect.